Observational study links elevated hs-cTnT levels to increased mortality and complications in NSTEMI patients, suggesting vital need for risk stratification.
Key Points
Elevated hs-cTnT levels closely correlate with higher in-hospital complication rates and mortality in NSTEMI patients, emphasizing its prognostic importance.
Patients with high hs-cTnT levels exhibited a significant increase in major adverse cardiovascular events (67% vs. 15%) compared to those with lower levels.
Prospective observational study involving 155 NSTEMI patients highlighted the critical role of hs-cTnT in risk assessment and management strategies.
Incorporating hs-cTnT into early management may improve patient outcomes by enabling timely interventions and better risk stratification.